间歇性禁食对NAFLD患者实验室、放射学和人体测量参数的影响。

IF 1.5 Q3 GASTROENTEROLOGY & HEPATOLOGY
Clinical and Experimental Hepatology Pub Date : 2022-06-01 Epub Date: 2022-05-30 DOI:10.5114/ceh.2022.115056
Hanaa Badran, Maha Elsabaawy, Ahmed Sakr, Mahmoud Eltahawy, Mahitab Elsayed, Dalia M Elsabaawy, Mervat Abdelkreem
{"title":"间歇性禁食对NAFLD患者实验室、放射学和人体测量参数的影响。","authors":"Hanaa Badran,&nbsp;Maha Elsabaawy,&nbsp;Ahmed Sakr,&nbsp;Mahmoud Eltahawy,&nbsp;Mahitab Elsayed,&nbsp;Dalia M Elsabaawy,&nbsp;Mervat Abdelkreem","doi":"10.5114/ceh.2022.115056","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim of the study: </strong>Despite the ample flow of non-alcoholic fatty liver disease (NAFLD) drugs in the pipeline, lifestyle modifications are still the optimal solution of NAFLD. The aim of the study was to assess short term effects of Ramadan fasting (RF) as a sort of intermittent fasting (IF) on biochemical, radiological, and anthropometric parameters of NAFLD patients.</p><p><strong>Material and methods: </strong>Ninety-eight NAFLD patients were recruited and voluntarily subjected to 16 hours daily fasting for an average of 22-29 days, without special dietary recommendations. Anthropometric, laboratory and radiological parameters were measured before, at 30 days, and one month after fasting (fasting and non-fasting phases).</p><p><strong>Results: </strong>Patients were mostly rural (76%), hypertensive (34.7%), diabetic (43.9%), and female (76.8%), with overt criteria of metabolic syndrome (67.3%). Liver transaminases (ALT and AST) were ameliorated significantly after fasting (<i>p</i> ≤ 0.01), which continued in the following month (<i>p</i> ≤ 0.01) especially in those with elevated ALT before fasting (46%). Eleven patients (24.4%) experienced ALT normalization after one month of fasting, which was further increased to 15 (33.3%) one month later. Lipid profiles (cholesterol, triglycerides, HDL, LDL, cholesterol/HDL risk ratio) were significantly corrected following IF (<i>p</i> ≤ 0.01) and continuing in the next phase (<i>p</i> ≤ 0.010). Body mass index (BMI) lessened following the fasting (<i>p</i> ≤ 0.01), while no remarkable changes were noted regarding waist, hip, and triceps skin fold thickness (<i>p</i> ≤ 0.01). Glycemic indices (HbA<sub>1c</sub>, postprandial, HOMA-IR) and fibrosis markers (FIB-4 and APRI) were significantly ameliorated (<i>p</i> ≤ 0.01), while reduction in inflammatory markers was not long lasting (<i>p</i> ≤ 0.01).</p><p><strong>Conclusions: </strong>Intermittent fasting led to momentous improvements in ultrasonographic, biochemical, and anthropometric parameters of NAFLD especially in early phases and prediabetics.</p>","PeriodicalId":10281,"journal":{"name":"Clinical and Experimental Hepatology","volume":"8 2","pages":"118-124"},"PeriodicalIF":1.5000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b1/e4/CEH-8-46765.PMC9442655.pdf","citationCount":"9","resultStr":"{\"title\":\"Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients.\",\"authors\":\"Hanaa Badran,&nbsp;Maha Elsabaawy,&nbsp;Ahmed Sakr,&nbsp;Mahmoud Eltahawy,&nbsp;Mahitab Elsayed,&nbsp;Dalia M Elsabaawy,&nbsp;Mervat Abdelkreem\",\"doi\":\"10.5114/ceh.2022.115056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim of the study: </strong>Despite the ample flow of non-alcoholic fatty liver disease (NAFLD) drugs in the pipeline, lifestyle modifications are still the optimal solution of NAFLD. The aim of the study was to assess short term effects of Ramadan fasting (RF) as a sort of intermittent fasting (IF) on biochemical, radiological, and anthropometric parameters of NAFLD patients.</p><p><strong>Material and methods: </strong>Ninety-eight NAFLD patients were recruited and voluntarily subjected to 16 hours daily fasting for an average of 22-29 days, without special dietary recommendations. Anthropometric, laboratory and radiological parameters were measured before, at 30 days, and one month after fasting (fasting and non-fasting phases).</p><p><strong>Results: </strong>Patients were mostly rural (76%), hypertensive (34.7%), diabetic (43.9%), and female (76.8%), with overt criteria of metabolic syndrome (67.3%). Liver transaminases (ALT and AST) were ameliorated significantly after fasting (<i>p</i> ≤ 0.01), which continued in the following month (<i>p</i> ≤ 0.01) especially in those with elevated ALT before fasting (46%). Eleven patients (24.4%) experienced ALT normalization after one month of fasting, which was further increased to 15 (33.3%) one month later. Lipid profiles (cholesterol, triglycerides, HDL, LDL, cholesterol/HDL risk ratio) were significantly corrected following IF (<i>p</i> ≤ 0.01) and continuing in the next phase (<i>p</i> ≤ 0.010). Body mass index (BMI) lessened following the fasting (<i>p</i> ≤ 0.01), while no remarkable changes were noted regarding waist, hip, and triceps skin fold thickness (<i>p</i> ≤ 0.01). Glycemic indices (HbA<sub>1c</sub>, postprandial, HOMA-IR) and fibrosis markers (FIB-4 and APRI) were significantly ameliorated (<i>p</i> ≤ 0.01), while reduction in inflammatory markers was not long lasting (<i>p</i> ≤ 0.01).</p><p><strong>Conclusions: </strong>Intermittent fasting led to momentous improvements in ultrasonographic, biochemical, and anthropometric parameters of NAFLD especially in early phases and prediabetics.</p>\",\"PeriodicalId\":10281,\"journal\":{\"name\":\"Clinical and Experimental Hepatology\",\"volume\":\"8 2\",\"pages\":\"118-124\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b1/e4/CEH-8-46765.PMC9442655.pdf\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Experimental Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/ceh.2022.115056\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/5/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/ceh.2022.115056","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/5/30 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 9

摘要

研究目的:尽管非酒精性脂肪性肝病(NAFLD)药物在管道中大量流动,但生活方式改变仍然是NAFLD的最佳解决方案。本研究的目的是评估斋月禁食(RF)作为一种间歇性禁食(IF)对NAFLD患者生化、放射学和人体测量参数的短期影响。材料和方法:招募了98名NAFLD患者,他们自愿每天禁食16小时,平均持续22-29天,没有特殊的饮食建议。在禁食前、禁食30天和禁食后1个月(禁食期和非禁食期)测量人体测量学、实验室和放射学参数。结果:患者以农村(76%)、高血压(34.7%)、糖尿病(43.9%)、女性(76.8%)为主,有明显的代谢综合征标准(67.3%)。肝转氨酶(ALT和AST)在空腹后明显改善(p≤0.01),并在空腹后一个月内持续改善(p≤0.01),尤其是空腹前ALT升高者(46%)。禁食1个月后ALT恢复正常11例(24.4%),禁食1个月后ALT恢复正常15例(33.3%)。脂质谱(胆固醇、甘油三酯、高密度脂蛋白、低密度脂蛋白、胆固醇/高密度脂蛋白风险比)在IF后显著纠正(p≤0.01),并在下一阶段继续纠正(p≤0.010)。禁食后体重指数(BMI)下降(p≤0.01),而腰、臀、肱三头肌皮褶厚度无显著变化(p≤0.01)。血糖指标(HbA1c、餐后、HOMA-IR)和纤维化指标(FIB-4、APRI)均有显著改善(p≤0.01),炎症指标降低时间不长(p≤0.01)。结论:间歇性禁食可显著改善NAFLD的超声、生化和人体测量参数,尤其是在早期和糖尿病前期。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact of intermittent fasting on laboratory, radiological, and anthropometric parameters in NAFLD patients.

Aim of the study: Despite the ample flow of non-alcoholic fatty liver disease (NAFLD) drugs in the pipeline, lifestyle modifications are still the optimal solution of NAFLD. The aim of the study was to assess short term effects of Ramadan fasting (RF) as a sort of intermittent fasting (IF) on biochemical, radiological, and anthropometric parameters of NAFLD patients.

Material and methods: Ninety-eight NAFLD patients were recruited and voluntarily subjected to 16 hours daily fasting for an average of 22-29 days, without special dietary recommendations. Anthropometric, laboratory and radiological parameters were measured before, at 30 days, and one month after fasting (fasting and non-fasting phases).

Results: Patients were mostly rural (76%), hypertensive (34.7%), diabetic (43.9%), and female (76.8%), with overt criteria of metabolic syndrome (67.3%). Liver transaminases (ALT and AST) were ameliorated significantly after fasting (p ≤ 0.01), which continued in the following month (p ≤ 0.01) especially in those with elevated ALT before fasting (46%). Eleven patients (24.4%) experienced ALT normalization after one month of fasting, which was further increased to 15 (33.3%) one month later. Lipid profiles (cholesterol, triglycerides, HDL, LDL, cholesterol/HDL risk ratio) were significantly corrected following IF (p ≤ 0.01) and continuing in the next phase (p ≤ 0.010). Body mass index (BMI) lessened following the fasting (p ≤ 0.01), while no remarkable changes were noted regarding waist, hip, and triceps skin fold thickness (p ≤ 0.01). Glycemic indices (HbA1c, postprandial, HOMA-IR) and fibrosis markers (FIB-4 and APRI) were significantly ameliorated (p ≤ 0.01), while reduction in inflammatory markers was not long lasting (p ≤ 0.01).

Conclusions: Intermittent fasting led to momentous improvements in ultrasonographic, biochemical, and anthropometric parameters of NAFLD especially in early phases and prediabetics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical and Experimental Hepatology
Clinical and Experimental Hepatology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
2.80
自引率
0.00%
发文量
32
期刊介绍: Clinical and Experimental Hepatology – quarterly of the Polish Association for Study of Liver – is a scientific and educational, peer-reviewed journal publishing original and review papers describing clinical and basic investigations in the field of hepatology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信